Coronavirus (COVID-19) FAQ

4th Jun 2020

It’s hard to escape news about COVID-19. And with good reason. As an organization on the front line of finding vaccines for diseases such as Coronavirus, our number one priority is the health and safety of our staff, our clinical trial participants, and the broader community. We have answered some of the most frequently asked questions below. If you have any other questions, please get in touch with us at 1800 243 733.

Is there any impact from Coronavirus (COVID-19) on clinical trials at Nucleus Network sites (Melbourne, Brisbane or Prism in Minnesota)?
Can I still participate in a Nucleus Network clinical trial?
Are clinical trials included under the ‘essential travel’ classification?
Does Nucleus Network have coronavirus / COVID-19 clinical trials?
Phone screening:
Medical screening (in clinic):
Outpatient visits (in clinic):
Have social distancing measures been implemented at Nucleus Network sites (Melbourne, Brisbane or Prism in Minnesota)?
What if I feel unwell after being admitted for a confinement period for a clinical trial?
Can I still have visitors during my stay at the facility?

With your help, we can make a difference in the containment of COVID-19 as together we work on developing the medicines of tomorrow.

Useful links: